Presidential Secretariat undergoes structural changes for an efficient service

Presidential Secretariat undergoes structural changes for an efficient service

February 20, 2022   02:35 pm

With the appointment of Mr. Gamini Senarath as the Secretary to the President, several structural changes are reportedly being made to make the work of the Presidential Secretariat more efficient.

New officers have been appointed to positions in units that serve the people directly, including the President’s Fund and the Public Relations Unit, according to the President’s Media Division.

“It should be noted that with the appointment of a new Secretary to the President, some social media outlets have tried to misinterpret the administrative changes being made using personal names, which are misleading,” the PMD statement said.

Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them(mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Most Viewed Video Stories

Plantation Minister reveals extent of Cyclone Ditwah's impact on plantation sector (English)

Plantation Minister reveals extent of Cyclone Ditwah's impact on plantation sector (English)

Court temporarily suspends MP Asoka Ranwala's driving licence, orders tests (English)

CoPF approves Rs. 500 billion supplementary estimate for disaster relief efforts (English)

Political parties and trade union demand answers over controversial medicine batch (English)

🔴LIVE Ada Derana Midday Prime News Bulletin

Disciplinary inquiry against several police officers over negligence in probing MP Asoka Ranwala's accident (English)

Govt presents Rs. 500 billion supplementary estimate as parliament debates on recent disaster (English)

Complaint filed with CID over Ondansetron vaccine which was withdrawn from use (English)